News

Filter

US and European oncologists see novel chemotherapies as best hope for soft tissue sarcoma

30-01-2013

Although interviewed oncologists in the USA and Europe would like to see a future of personalized medicine…

BiotechnologyEisaiEuropeHalavenIfosfamideMarkets & MarketingOncologyPfizerPharmaceuticalTH-302Threshold PharmaceuticalsXalkoriZiopharm OncologyZymaphos

Merck Serono initiation of TH-302 Ph III trial triggers $30 million milestone for Threshold

29-01-2013

Merck Serono, the pharma division of Germany's Merck KGaA (MRK: DE), has initiated the global Phase III…

FinancialMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302Threshold Pharmaceuticals

News briefs from Threshold, Merck KGaA and GSK

18-09-2012

US biotech firm Threshold Pharmaceuticals (Nasdaq: THLD) said yesterday that data from a Phase IIb trial…

BiotechnologyErbituxEuropeGlaxoSmithKlineMerck KGaAMerck SeronoOncologyPharmaceuticalRegulationResearchSynflorixTH-302Threshold PharmaceuticalsVaccines

Merck KGaA licenses pancreatic cancer drug from Threshold

06-02-2012

Merck Serono, a division of German pharma and chemical major Merck KGaA (MRK: DE) has signed a global…

BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceuticalThreshold Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top